Comparison of GLP-1 Analogues versus Sitagliptin in the Management of Type 2 Diabetes: Systematic Review and Meta-Analysis of Head-to-Head Studies

Open Access

Peer-reviewed

Research Article

Tiansheng Wang,

Affiliations Department of Pharmacy Administration and Clinical Pharmacy, Peking University Health Science Center, Beijing, China, Department of Pharmacy, Peking University Third Hospital, Beijing, China
⨯
Zhuoyue Gou,

Affiliation Department of Pharmacy, First Affiliated Hospital of Harbin Medical University, Harbin, China
⨯
Fei Wang,

Affiliation Department of Pharmacy Practice, School of Pharmacy, University of Connecticut, Storrs, Connecticut, United States of America
⨯
Manling Ma,

Affiliation Department of Pharmacy, First Affiliated Hospital of Harbin Medical University, Harbin, China
⨯
Suo-di Zhai

* E-mail: zhaisuodi@163.com

Affiliation Department of Pharmacy, Peking University Third Hospital, Beijing, China
⨯

Reader Comments (0)

Metaanalysis
Is the Subject Area "Metaanalysis" applicable to this article?

Thanks for your feedback.
Type 2 diabetes risk
Is the Subject Area "Type 2 diabetes risk" applicable to this article?

Thanks for your feedback.
Adverse events
Is the Subject Area "Adverse events" applicable to this article?

Thanks for your feedback.
HbA1c
Is the Subject Area "HbA1c" applicable to this article?

Thanks for your feedback.
Randomized controlled trials
Is the Subject Area "Randomized controlled trials" applicable to this article?

Thanks for your feedback.
Type 2 diabetes
Is the Subject Area "Type 2 diabetes" applicable to this article?

Thanks for your feedback.
Body weight
Is the Subject Area "Body weight" applicable to this article?

Thanks for your feedback.
Blood pressure
Is the Subject Area "Blood pressure" applicable to this article?

Thanks for your feedback.